Regulation and potential drug targets of tumor-associated Tregs

by Science China PressRegulatory T cells (Tregs) negatively regulate the antitumour immune responses by inhibiting the function of effector T cells (CTL) and antigen presenting cells (APC). Credi

Updated on: April 07,2024

Regulation and potential drug targets of tumor-associated Tregs

by Science China PressRegulatory T cells (Tregs) negatively regulate the antitumour immune responses by inhibiting the function of effector T cells (CTL) and antigen presenting cells (APC). Credi

Updated on:April 07,2024

Looking for cancer information: Can ChatGPT be counted on?

by Huntsman Cancer InstituteCredit: Pixabay/CC0 Public DomainAstudyin theJournal of The National Cancer Institute Cancer Spectrumlooked at chatbots and artificial intelligence

Updated on: January 15,2024

Looking for cancer information: Can ChatGPT be counted on?

by Huntsman Cancer InstituteCredit: Pixabay/CC0 Public DomainAstudyin theJournal of The National Cancer Institute Cancer Spectrumlooked at chatbots and artificial intelligence

Updated on:January 15,2024

Doctor gets first US lung-liver transplant for advanced lung cancer

by Dennis ThompsonDr. Gary Gibbon didn't have long to live. A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently destroyed his lungs and cause

Updated on: March 30,2024

Doctor gets first US lung-liver transplant for advanced lung cancer

by Dennis ThompsonDr. Gary Gibbon didn't have long to live. A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently destroyed his lungs and cause

Updated on:March 30,2024

New class of drugs could treat ovarian cancer

by Mike Addelman,University of ManchesterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous ep

Updated on: May 17,2024

New class of drugs could treat ovarian cancer

by Mike Addelman,University of ManchesterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous ep

Updated on:May 17,2024

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in

Updated on: December 28,2023

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in

Updated on:December 28,2023

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s

Updated on: January 30,2024

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s

Updated on:January 30,2024

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc

Updated on: April 09,2024

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc

Updated on:April 09,2024

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on: January 11,2024

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on:January 11,2024

Focused delivery for brain cancers

by Brandie Jefferson,Washington University in St. LouisHong Chen, assistant professor of biomedical engineering in the School of Engineering & Applied Science and assistant professor of radi

Updated on: March 12,2024

Focused delivery for brain cancers

by Brandie Jefferson,Washington University in St. LouisHong Chen, assistant professor of biomedical engineering in the School of Engineering & Applied Science and assistant professor of radi

Updated on:March 12,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on: January 04,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on:January 04,2024

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on: February 18,2024

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on:February 18,2024

New study outlines how brain cancer cells take mitochondria from healthy cells to grow and survive

byCleveland ClinicThis is an astrocyte, labeled with GFAP (red), Focal Adhesion Kinase (FAK) green, and nuclear stain To-Pro (blue). Credit: Ivey and MacLean at TNPRC. Via Wikipedia.Glioblastoma

Updated on: January 12,2024

New study outlines how brain cancer cells take mitochondria from healthy cells to grow and survive

byCleveland ClinicThis is an astrocyte, labeled with GFAP (red), Focal Adhesion Kinase (FAK) green, and nuclear stain To-Pro (blue). Credit: Ivey and MacLean at TNPRC. Via Wikipedia.Glioblastoma

Updated on:January 12,2024